Patent · US Active

Anti-Vβ17/anti-CD123 bispecific antibodies

US12264197B2 · kind B2 · utility

0Cited by

9References

25Claims

0Family size

Assignee

JANSSEN BIOTECH, INC. · US

Inventors

Rajkumar Ganesan · Blue Bell, US
Iqbal Grewal · Newtown, US
Manuel Sepulveda · Princeton Junction, US

Key dates

Filing date	Mar 11, 2020
Grant date	Apr 1, 2025
Priority date	—
Expiry date	Jun 16, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Anti-Vβ17/anti-CD123 bispecific antibodies or antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, methods of producing the antibodies, and methods of using the antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.